Every Form 4 that Clearmind Medicine Inc. (CMND) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CMND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMND filings page.
HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported an open‑market sale of 22,139 Class A Shares at $3.306 per share. After this transaction, HRT Financial LP directly holds 81,353 Class A Shares.
HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported an open-market sale of 3,183 shares of Common Stock at $3.32 per share. After this transaction, HRT Financial LP directly holds 103,492 Clearmind Medicine common shares, indicating it retained the vast majority of its position.
Clearmind Medicine Inc. insider HRT Financial LP reported an open-market sale of 2,102 shares of Common Stock. The shares were sold at a price of $3.36 per share. After this transaction, HRT Financial LP directly holds 106,675 shares of Clearmind Medicine common stock.
HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported mixed trading in the company’s common stock. On June 10, it executed an open-market purchase of 2,159,052 shares at $0.153 per share. On June 11, it made an open-market sale of 225,191 shares at $0.123 per share. After these transactions, HRT Financial LP directly held 1,838,075 shares of Clearmind Medicine common stock, indicating it was a net buyer over the two days.